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Abstract
Mathematical models of mitochondrial bioenergetics provide powerful analytical tools to help interpret experimental data
and facilitate experimental design for elucidating the supporting biochemical and physical processes. As a next step
towards constructing a complete physiologically faithful mitochondrial bioenergetics model, a mathematical model was
developed targeting the cardiac mitochondrial bioenergetic based upon previous efforts, and corroborated using both
transient and steady state data. The model consists of several modified rate functions of mitochondrial bioenergetics,
integrated calcium dynamics and a detailed description of the K
+-cycle and its effect on mitochondrial bioenergetics and
matrix volume regulation. Model simulations were used to fit 42 adjustable parameters to four independent experimental
data sets consisting of 32 data curves. During the model development, a certain network topology had to be in place and
some assumptions about uncertain or unobserved experimental factors and conditions were explicitly constrained in order
to faithfully reproduce all the data sets. These realizations are discussed, and their necessity helps contribute to the
collective understanding of the mitochondrial bioenergetics.
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Introduction
Motivation for Model Study
The simulation of mathematical models of mitochondrial
bioenergetics provides a powerful analytical alternative to perform-
ing numerous exhaustive experiments. Such models aid in the
interpretation of experimental data and facilitate experimental
design for elucidating the supporting biochemical and physical
processes. Current experimental techniques limit the ability to
resolve details of the mitochondrial bioenergetic processes in vivo.
Specifically, many different chemical species and events must be
simultaneously monitored to track the profusion of enzymatic
reactions involved in the tricarboxylic acid (TCA) cycle, b-
oxidation, the electron transport system (ETS), ATP synthesis and
electrolyte dynamics. Currently, it is impossible to accurately and
simultaneously measure all of these enzymatic processes in vivo with
any degree of precision. Nevertheless, a plethora of experimental
data is available on mitochondrial bioenergetics that was collected
using a variety of techniques, experimental conditions, and tissue
sources. No existing experimental data set is complete that consists
of measurements of all of the supporting chemical species and
events; therefore, the correct interpretation of the available
experimental data in isolation or as a collective unit is difficult.
This requires careful consideration of all potential data-consistent
dynamics of the unobserved species and events. To aid in the
interpretation, a quantitative framework established via mathemat-
ical model development and parameter identification through
experiment simulation is commonly employed in a collective
manner so that a data-compatible, semi-mechanistic description
of the underlying bioenergetic processes emerges. With the addition
of each new experimental data set, the model matures either
through corroboration via evidence that supports the hypothesized
mechanisms encoded within the mathematical representation or
through modification of the model structure and parameters to
refine and/or reveal more insights and alter the supporting
hypothesized mechanisms underlying bioenergetic processes.
Several mathematical models have been developed [1–6] to
describe aspects of mitochondrial bioenergetics, but none currently
capture the complete dynamics of all metabolically relevant ion
and substrate regulatory functions observed during physiological
and pathophysiological conditions. As the next step towards
constructing a complete physiologically faithful mitochondrial
bioenergetics model, this manuscript describes the development
and corroboration of a mathematical model based on cardiac
mitochondria that builds upon these previously published models.
The Yugi and Tomita model [6] simulates mitochondrial
bioenergetics with the most breadth. They have compiled a large
mitochondrial bioenergetics model that qualitatively captures the
basic mitochondrial bioenergetic phenomena and included much
of the mitochondrial biochemistry from a variety of species and
organs. Although the Yugi and Tomita model has been
successfully modified to predict the dynamic response of b-
oxidation in the context of human disease [7], it does not
incorporate some details required to reproduce a few specific
bioenergetic regulatory features of interest herein. The Wu et al.
model [1] was chosen as the base model for this work due to its
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various biochemical species present in the mitochondrial milieu.
Our model structure and the parameter values were selected so
that simulations of the experimental conditions on porcine or rat
heart mitochondria simultaneously fit the inorganic phosphate (Pi)
control over mitochondrial bioenergetics [8] and TCA interme-
diate dynamics [9] data sets upon which the Wu et al. model was
developed as well as additional experimental data on the extra-
mitochondrial calcium-dependent steady state matrix calcium
concentrations [10] and mitochondrial matrix volume dynamics
[11]. Numerous other experimental studies were used to fit
constants for the employed rate expressions as described in the
Supplemental Material (Text S1). The resulting extended model is
corroborated with additional experimental data on the steady state
behavior of the TCA cycle [9], volume dynamics under various
bioenergetic/pharmacological interventions [11] and the bioener-
getic/volume responses of mitochondria to variations in buffer
osmolarity [12]; a local sensitivity analysis was also used to explore
the robustness of the model structure relative to these simulated
experiments. This manuscript describes all phases of this process
including the model development, parameter estimation and
corroboration. It concludes with a discussion of the insights on the
bioenergetic processes obtained during the model extension.
Results
Model Development
The model integrates mitochondrial bioenergetic processes as
shown in Figure 1 including oxidative phosphorylation, the ETS,
the TCA cycle and related reactions, the Na
+/Ca
2+ cycle and the
K
+-cycle. To maintain thermodynamic consistency, all reactions in
the model, as shown in Table 1, are represented as thermody-
namically balanced and reversible. (It should be noted that some of
the reactions could have been treated as irreversible reactions since
the conditions necessary to reverse them lie very far from
physiological conditions.) The model is primarily based on the
mitochondrial bioenergetics model proposed by Wu et al. [1] and
extended to address: 1) updated formalisms for the calcium-
sensitive dehydrogenases, as well as, several modified TCA cycle
related rate expressions; 2) a two-site model for the adenine
nucleotide transporter [13]; 3) the Na
+/Ca
2+ cycle including a
non-linear dependence on inner mitochondrial membrane poten-
tial difference, yinside - youtside,( Dy) for the calcium uniporter
(CaUNI) [14], magnesium inhibition kinetics for the CaUNI, and
the proton-regulation of the mitochondrial Na
+/H
+ exchanger
(mNHE); and 4) the K
+-cycle including the mitochondrial ATP-
dependent K
+ channel (mKATP), electrophoretic K
+-leak and the
mitochondrial K
+/H
+ exchanger (mKHE) with the mitochondrial
matrix volume regulation dynamics hypothesized by Garlid [15].
Each addition is described in the following paragraphs.
The model proposed in the manuscript is a 73 state system of
differential-algebraic equations (DAEs) that consists of 65 non-
linear ordinary differential equations (ODEs); five algebraic
conservation expressions to compute matrix ATP, guanidine
triphosphate (GTP), reduced nicotinamide adenine dinucleotide
(NADH), ubiquinol (UQH2) and reduced cytochrome c (c
2+); one
algebraic expression to compute matrix water volume; one
algebraic expression to compute inner membrane space (IMS)
water volume and one algebraic expression to compute matrix
chloride content (Cl
2). The majority of the experimental data used
to parameterize the model proposed in this manuscript were
derived from heart tissue of either bovine, porcine or rat with some
data obtained from liver tissue. Part S1 of the Supplemental
Material (Text S1) lists the state variables and general parameters,
Part S2 contains the system of DAEs comprising the model and
Part S3 provides a detailed description of the rate expressions and
their parameters used to construct the system of DAEs. Part S3
also includes the fitness for some rate expressions calibrated with
additional experimental data not explicitly indicated in this
manuscript.
The TCA and related enzyme rate expressions are structurally
identical to Wu et al. except for a few alterations. To include the
calcium-dependence of matrix dehydrogenases, the rate expres-
sions for pyruvate dehydrogenase (PDH), isocitrate dehydrogenase
(IDH) and a-ketoglutarate dehydrogenase (aKGDH) were mod-
ified. PDH, an important regulatory enzyme involved with
mitochondrial bioenergetics, is responsible for the oxidative
decarboxylation of pyruvate, transacylation of an acetyl group to
CoA and production of reducing equivalents for the ETS. A
similar rate expression found in Wu et al. was used with a few
notable modifications. The proton, divalent cation and adenine
nucleotide regulatory mechanisms were inserted into the expres-
sion to reproduce the available data [16]. IDH is responsible for
the oxidative decarboxylation of isocitrate to produce a-ketoglu-
tarate and reducing equivalents for the ETS. The rate expression
used in the model is from Qi et al. [17]. The key TCA regulatory
enzyme, aKGDH, is responsible for the oxidative decarboxylation
of a-ketoglutarate transferring a succinyl group to CoA and
producing reducing equivalents for the ETS. The consensus hexa-
uni-ping-pong mechanism with the appropriate activation and
inhibition modifications was used to reproduce a wide variety of
data from four independent data sets [18–21].
Two additional rate expressions that deviated from Wu et al. are
the glutamate-aspartate exchanger (GAE) and dicarboxylate
carrier (DCC). The GAE is a key enzyme in the malate-aspartate
shuttle and is particularly important maintaining state 3 NADH
levels when mitochondria respire on glutamate and malate. This
electrogenic exchanger is activated by calcium and swaps
glutamate and a proton with aspartate taking advantage of the
energized state of mitochondria established by the ETS. The
enzyme reaction was modeled based on a rapid equilibrium bi-bi
mechanism with a third substrate, protons, added to the rate
Author Summary
Mathematically modeling biological systems challenges
our current understanding of the physical and biochemical
events contributing to the observed dynamics. It requires
careful consideration of hypothesized mechanisms, model
development assumptions and details regarding the
experimental conditions. We have adopted a modeling
approach to translate these factors that explicitly considers
the thermodynamic constraints, biochemical states and
reaction mechanisms during model development. Such
models have numerous constant parameters that must be
determined. Integrating thermodynamics and detailed
mechanistic representation of the principal phenomena
help constrain these parameter values; therefore, only a
handful of the total number of model parameters (,10%)
must be adjusted during parameter estimation through
model simulations. Additionally, all models must undergo
some form of corroboration prior to application. In
practice, this corroboration should challenge all possible
dynamics of the model, but it is recognized that in this
data rich world, we are surprisingly data poor. Eventually
such developed and corroborated models are capable of
supporting current hypotheses, guiding experimental
designs and contributing to the overall knowledge base
of biological processes.
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[22–23]. The DCC exchanges TCA cycle intermediates malate,
succinate and hydrogen phosphate. This exchanger was also
modeled as forming a ternary complex with its substrates, and the
kinetic parameters were fit to rat liver mitochondrial experimental
data [24–25].
The ANT is the enzyme responsible for exchanging unchealated
ATP and ADP across the mitochondrial inner membrane.
Previous models used a ping-pong mechanism that employed a
single adenine nucleotide binding site whereby Dy affected only
ATP binding [26]. This type of mechanism has been shown to
inadequately describe the enzyme kinetics, and studies have
identified at least two distinct adenine nucleotide binding sites
[27–28]. The model presented by Metelkin et al. [13] addresses
these issues and was therefore chosen to describe the ANT kinetics.
The parameters were refit to the original data to include the effect
of Na
+ and K
+ chelation of adenine nucleotides.
The model proposed in this manuscript incorporates mitochon-
drial calcium dynamics similar to Nguyen et al. [2], Cortassa et al.
[3] and Dash and Beard [14]. The CaUNI is similar to the
expression found in Dash and Beard including the nonlinear
dependence on Dy with the addition of explicit magnesium
inhibition based on experimental data. In Part S3 of the
Supplemental Material (Text S1), the magnesium inhibition was
used to show that a single calcium dissociation constant with
magnesium acting as a competitive inhibitor against calcium
binding for the channel is capable of reproducing the experimental
data (consisting of both rat heart and liver mitochondria). The
Figure 1. A graphical representation of the bioenergetic elements and processes described by the model. Abbreviations: Oxphos,
oxidative phosphorylation elements; PYR, pyruvate; CoASH, coenzyme A; AcCoA, acetyl-coenzyme A; CIT, citrate; ISOC, isocitrate; aKG, a-
ketoglutarate; SCoA, succinyl CoA; SUC, succinate; FUM, fumarate; MAL, malate; OAA, oxaloacetate; GLU, glutamate; ASP, aspartate; NADH, reduced
nicotinamide adenine dinucleotide; NAD, GTP, guanidine triphosphate; GDP, guanidine diphosphate; oxidized nicotinamide adenine dinucleotide; Pi,
inorganic phosphate; UQ, ubiquinone; UQH2, ubiquinol; Cytc
3+, oxidized cytochrome c; Cytc
2+, reduced cytochrome c; PDH, pyruvate dehydrogenase;
CS, citrate synthase; ACH, acontinase; IDH, isocitrate dehydrogenase; aKGDH, a-ketoglutarate dehydroganse; SCoAS; succinyl CoA synthetase; SDH,
succinate dyhdrogenase; FH, fumarate hydratase; MDH, malate dehydrogenase; GOT, glutamate oxaloacetate transaminase; CI, Complex I; CIII,
Complex III; CIV, Complex IV; mHleak, proton leak; F1FO,F 1FO ATP synthase; ANT, adenine nucleotide transporter; PIC, inorganic phosphate carrier;
GAE, glutamate/aspartate exchanger; OME, a-ketoglutarate/malate exchanger; DCC, dicarboxylate carrier; TCC, tricarboxylate carrier; PYRH, pyruvate-
proton cotransporter; GLUH, glutamate-proton cotransporter; mKATP, ATP-dependent K
+ channel; mKHE, K
+/H
+ exchanger; mKleak, K
+ leak; mNHE,
Na
+/H
+ exchanger; mNCE, Na
+/Ca
2+ exchanger; CaUNI, Ca
2+ uniporter; AK, adenylate kinase.
doi:10.1371/journal.pcbi.1000632.g001
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hypothetical matrix calcium activation mechanism. This calcium
activation mechanism resulted in comparable dynamics under the
calcium loading experiments used to fit Dash and Beard’s matrix
calcium inhibition mechanism for the CaUNI but was extended to
be analogous with the current experimental evidence regarding
the sarcolemmal isoform [29]. The mNHE was slightly modified
from Nguyen et al. to include a hill coefficient of 2 for the proton
regulation mechanism.
The ‘futile’ K
+-cycle plays a major role in mitochondrial volume
homeostasis [30–34]. Potassium influx via the mKATP and
electrophoretically driven potassium uptake via leak pathways
must be balanced with potassium efflux from the mKHE.
Originally, the mKHE was thought to be regulated by the carrier
brake hypothesis [35]. This essentially involves some endogenous
element in the matrix, such as magnesium, that serves as the
‘‘carrier brake’’ that is reversibly released by matrix swelling.
Brierley and Jung call into question this hypothesis noting that
under physiological conditions, the known inhibitors of the
exchanger are present at concentrations much greater than their
respective inhibitory constants [36]. Garlid then proposed that the
mKHE is additionally regulated by matrix volume with membrane
Table 1. Modeled Mitochondrial Bioenergetic Reactions.
Reaction Enzyme Biochemical Reaction
Mitochondrial Reactions
JPDH Pyruvate dehydrogenase PYR + CoASH + NAD + H2O « CO2 + SCOA + NADH
JCS Citrate synthase OAA + AcCoA + H2O « CoASH + CIT
JACH Aconitase CIT « ISOC
JIDH Isocitrate dehydrogenase NAD + ISOC + H2O « aKG + NADH + CO2
JaKGDH a-Ketoglutarate dehydrogenase aKG + CoASH + NAD + H2O « CO2 + SCoA + NADH
JSCoAS Succinyl CoA synthase SCoA + GDP + Pi « SUC + GTP + CoASH
JSDH Succinate dehydrogenase SUC + UQ « UQH2 + FUM
JFH Fumarate hydratase FUM + H2O « MAL
JMDH Malate dehydrogenase NAD + MAL « OAA + NADH
JNDK Nucleoside diphosphokinase GTP + ADP « GDP + ATP
JGOT Glutamate oxaloacetate transaminase ASP + aKG « OAA + GLU
JCI Complex I NADH + UQ « NAD + UQH2
JCIII Complex III UQH2 + 2Cytc
3+ « UQ + 2Cytc
2+
JCIV Complex IV 2Cytcred + KO2 « 2Cytcox + H2O
JF1FO F1FO ATP synthase ADP + Pi « ATP + H2O
JAK Adenylate Kinase 2ADP « ATP + AMP
Exchangers and Ion Channels
JGAE Glutamate-aspartate exchanger GLUims + H
+
ims + ASPmtx « GLUmtx + H
+
mtx + ASPims
JOME a-Ketoglutarate-malate exchanger aKGims + MALmtx « aKGmtx + MALims
JPYRH Pyruvate-proton cotransporter PYRims + H
+
ims « PYRmtx + H
+
mtx
JGLUH Glutamate-proton cotransporter GLUims + H
+
ims « GLUmtx + H
+
mtx
JCITMAL Tricarboxylate carrier CITims + MALmtx « CITmtx + MALims
JISCOMAL Tricarboxylate carrier ISOCims + MALmtx « ISOCmtx + MALims
JSUCPi Dicarboxylate carrier SUCmtx + Piims « SU Cims + Pimtx
JMALPi Dicarboxylate carrier MALmtx + Piims « MALims + Pimtx
JANT Adenine nucleotide transporter ATPmtx + ADPims « ATPims + ADPmtx
JPIC Inorganic phosphate carrier Piims + H
+
ims « Pimtx + H
+
mtx
JmHleak Proton leak H
+
ims « H
+
mtx
JmKHE Potassium-hydrogen exchanger H
+
ims + K
+
mtx « K
+
ims + H
+
mtx
JmKATP ATP-dependent potassium channel K
+
ims « K
+
mtx
JmKleak Potassium leak K
+
ims « K
+
mtx
JCaUNI Calcium uniporter Ca
2+
ims « Ca
2+
mtx
JmNCE Sodium-calcium exchanger Ca
2+
mtx + 3Na
+
ims « Ca
2+
ims + 3Na
+
mtx
JmNHE Sodium-hydrogen exchanger Na
+
mtx + H
+
ims « Na
+
ims + H
+
mtx
Other Reactions Used in the Model
JHK Hexokinase
a GLC + ATP « G6P + ADP
abbrev: mtx, matrix; ims, intermembrane space.
aReaction is not presented in Figure 1.
doi:10.1371/journal.pcbi.1000632.t001
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mechanism is provided by the results of the analysis of the
mathematical model proposed in this manuscript discussed below.
Parameter Estimation
To parameterize the model, four independent data sets
consisting of 32 data curves were used from Bose et al. [8],
LaNoue et al. [9], Wan et al. [10] and Kowaltowski et al. [11]. In
the manuscript these studies will be henceforth referenced as the
Bose data set, LaNoue data set, Wan data set and Kowaltowski
data set, respectively. For each data set, the model was initialized
from a condensed, fully oxidized and de-energized state via
initialization simulations that replicated the experimental incuba-
tion conditions (i.e. Pi- and Ca
2+-depletion) prior to parameter
estimation. The parameter identification was subsequently con-
ducted using simulation conditions closely mimicking those
of the experimental methods. The resulting values of the 42
adjustable parameters, their definitions, their best fit values and
their associated normalized local sensitivity coefficients (LSC) are
provided in Table 2. The following paragraphs describe the ability
of the model with these fitted parameter values to reproduce the
experimental results from these four independent experimental
data sets; pertinent details of the experimental conditions and their
replication through model simulations are described in the
Methods section.
The NADH-linked respiration components of the model were
fitted against the Pi-titration experiments performed by Bose et al.
[8]. In their manuscript, the authors reported a rich bioenergetic
data set using glutamate/malate energized, Pi-depleted mitochon-
dria under both state 2 and state 3 respiration conditions. State 3
was initiated and maintained with a sufficient bolus addition of
1.3 mM ADP. At this concentration, maximum respiration was
maintained for at least half a minute before the ANT exerted its
control due to limited substrate availability. Mitochondrial Dy,
NAD/NADH redox state, myocardial oxygen consumption
(MVO2), cytochrome c
3+/c
2+ redox state and matrix pH were
reported as the extra-mitochondrial Pi was progressively increased
from 0 to 10 mM. Figure 2 shows that the model was capable of
fitting this data set. Similar to the Wu et al. model, the model
presented in this manuscript produced state 3 Dy that reproduced
the Pi-titration trend but at 10–15 mV lower than the experi-
mentally measured state 3 Dy. To achieve the low matrix pH
levels observed experimentally, the mKHE was temporarily
replaced with an expression with sufficient activity to rapidly
equilibrate [K
+]mtx[H
+]ims/[K
+]ims/[H
+]mtx, and the initial matrix
[K
+] was adjusted to approximately 125 mM. Without these
modifications for this data set, the model produced matrix pH of
up to 7.2–7.5 pH units under the experimental conditions
simulated. This issue is further explored in the Discussion. Overall,
the experimentally reported Dy, NAD/NADH redox state and
MVO2 Pi-titrations as well as the expected increase in volume with
increasing Pi are captured by the model.
The TCA cycle intermediate dynamics of the model were fitted
to the data set presented by LaNoue et al. [9]. In their
experiments, they used pyruvate/malate and pyruvate energized
mitochondria in both state 2 and state 3 respiration. State 3 was
initiated by the addition of 0.5 mM ADP and maintained using a
hexokinase trap. They reported detailed time series data of most of
the TCA cycle intermediates for each experimental condition. The
model was able to capture the salient features of the pyruvate/
malate energized mitochondrial TCA cycle intermediate dynamics
as shown in Figure 3. The model simulated pyruvate, citrate,
isocitrate, a-ketoglutarate, succinate and malate transients similar
to the experimental data. Figure 4 shows that the simulated
aspartate and glutamate dynamics using pyruvate energized
mitochondria under both state 2 and state 3 respiratory conditions
were also consistent with experimental data. In these simulations,
the endogenous matrix aspartate content provided sufficient
amino acid substrates for glutamate oxaloacetate transaminase
(GOT) while glutamate efflux via glutamate-H
+ cotransporter
reduced the total available matrix asparate/glutamate pool.
The Na
+/Ca
2+ cycle was fitted to the steady state data from
Wan et al. [10]. In their experiments, they used ATP-energized
mitochondria and monitored steady state Ca
2+ levels at varying
extra-mitochondrial Ca
2+,N a
+ and Mg
2+ concentrations. The
ATP initialized the mitochondrial Dy to approximately 2120 mV
in the model simulations corroborating the data reported by
Territo et al. [37]. The model’s capability of fitting the extra-
mitochondrial Ca
2+- and Na
+-dependence on matrix steady state
Ca
2+ concentrations is illustrated in Figure 5. The steady sate
matrix free Ca
2+ data in the absence of extra-mitochondrial Na
+ is
not shown nor was used in the parameter estimation, because the
Na
+-independent calcium efflux was not included in the model
structure. (Note, with an electroneutral Ca
2+/2H
+ exchange
mechanism, the Na
+-independent steady state matrix Ca
2+ data
could be reproduced by the model; however, this mechanism was
not included in the current model formulation. The rationale for
this choice is described in more detail in the Discussion.)
The volume dynamics were fitted to the transient mitochondrial
matrix swelling data published by Kowalowski et al. [11]. They
measured the effect of varying matrix ATP levels on the swelling
dynamics in K-salt media with succinate-energized mitochondria.
Figure 6 shows that the volume dynamics were captured well by
the model. When a small amount of ATP was included in the
buffer in the presence of oligomycin, a F1FO ATP synthase
inhibitor, the mitochondria swelled to approximately 1.5 mL/mg
in about four minutes. When the ATP was supplemented with
ADP, oxidative phosphorylation was activated which lowered the
Dy and generated matrix ATP. This reduced the electrophoretic
potassium uptake and inhibited the mKATP channel, respectively,
so that the steady state volume reached a lower value of
approximately 1.2 mL/mg. When ATP was not present, all
residual matrix ATP was converted to ADP via reverse activation
of the F1FO ATP synthase. This fully activated the mKATP
channel, so that the final steady state volume reached a much
higher value of about 2.0 mL/mg.
Corroborating the Model through Simulation
Model corroboration was necessary to establish confidence in
the model resulting from these efforts. Herein, the corroboration
considered the robustness of the model to local parameter
perturbations, the qualitative agreement of predicted trends with
experimental observations, and the ability of the model to
reproduce experimental data that was not used in fitting its
parameters.
A local sensitivity analysis on the model was performed to
determine how robust the model simulations were to local
perturbations in the parameter values of all the experiments used
in the parameter identification. The absolute-value normalized
local sensitivity coefficients (LSC) were computed using Equation 2
as defined in the Methods section which considered variations for
every state variable dynamics uniformly throughout the simulated
experiment duration. The average LSC of all 359 parameters was
only 7.38610
23 with a variance of 1.18610
23. This implies on
average that a perturbation of 1% for a given parameter results in
less than a 0.738 +/2 0.118% change in the state dynamics of the
model for the experiments considered. Of the 42 adjustable
parameters, the average of the absolute-value normalized LSC
Modeling Mito. Bioenergetics with Volume Dynamics
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Parameter Definition Value (LSCx100) Units
VPDH
max Pyruvate dehydrogenase max rate 127 (4.88) nmol/min/mg
VCS
max Citrate synthase max rate 584 (1.64) nmol/min/mg
VACH
mf Acontinase max forward rate 1.16610
5 (0.011) nmol/min/mg
VIDH
max Isocitrate dehydrogenase max rate 6.84610
4 (0.341) nmol/min/mg
VaKGDH
max a-Ketoglutarate dehydrogenase max rate 779 (2.18) nmol/min/mg
VSCoAS
mf Succinyl CoA synthase max forward rate 3.93610
4 (0.216) nmol/min/mg
VSDH
mf Succinate dehydrogenase max forward rate 7.00610
3 (2.26) nmol/min/mg
VFH
mf Fumurate hydratase max forward rate 7.67610
5 (0.010) nmol/min/mg
VMDH
mf Malate dehydrogenase max forward rate 965 (0.432) nmol/min/mg
KMDH
Pi Malate dehydrogenase Pi binding constant 5.00610
23 (0.156) M
b
MDH
Pi Malate dehydrogenase Pi activation constant 57.7 (0.193) unitless
VNDK
mf Nucleoside diphosphokinase max forward rate 6.95610
3 (0.016) nmol/min/mg
VGOT
mf Glutamate oxaloacetate transaminase max forward rate 1.09610
6 (0.251) nmol/min/mg
VPYRH
max Pyruvate-hydrogen co-transporter activity 3.12610
13 (0.651) nmol/M
2/min/mg
VGLUH
max Glutamate-hydrogen co-transporter activity 9.44610
10 (0.763) nmol/M
2/min/mg
VTCC
max Tricarboxylate activity 7.13610
8 (0.471) nmol/M
2/min/mg
VOME
max a-Ketoglutarate-malate exchanger max forward rate 8.83610
3 (0.275) nmol/min/mg
VGAE
o Glutamate-aspartate exchanger un-stimulated max rate 674 (0.865) nmol/min/mg
b
GAE
Ca Glutamate-aspartate calcium activation constant 27.2 (0.299) unitless
VDCC
max Dicarboxylate carrier max rate 8.03610
3 (0.901) nmol/min/mg
VCI Complex I activity 5.63610
6 (0.962) nmol/M
2/min/mg
VCIII Complex III activity 5.84610
5 (2.19) nmol/M
3/2/ming/mg
KCIII
Pi Complex III Pi binding constant 4.40610
23 (0.976) M
b
CIII
Pi Complex III Pi activation constant 148 (1.54) unitless
VCIV Complex IV activity 44.0 (2.19) nmol/M/min/mg
V
F1FO
mf F1FO ATP synthase activity 1.91610
7 (0.027) nmol/M/min/mg
VANT
mf Adenine nucleotide translocase max rate 365 (7.52) nmol/min/mg
VPIC
max Inorganic phosphate carrier max rate 7.59610
7 (0.012) nmol/min/mg
PmHleak
H Proton permeability 8.06610
7 (5.01) nmol/M/min/mg
VmKHE
max Potassium-hydrogen exchanger max rate 6.25 (3.58) nmol/nl/min/mg
GmKATP
K ATP-dependent potassium channel conductance 6.75 (0.181) nmol/min/mg
KmKATP
iMgATP ATP-dependent potassium channel MgATP inhibition constant 4.10610
29 (0.061) M
KmKATP
iMgADP ATP-dependent potassium channel MgADP inhibition constant 10.0610
26 (0.063) M
PmKleak
K Potassium permeability 13.8 (4.87) nmol/M/min/mg
PCaUNI
Ca Calcium uniporter calcium permeability 157 (0.403) nmol/min/mg
VmNCE
max Sodium-calcium exchanger max rate 0.731 (0.360) nmol/min/mg
KmNCE
Ca Sodium-calcium exchanger calcium binding constant 4.17610
26 (0.326) M
KmNCE
Na Sodium-calcium exchanger sodium binding constant 1.72610
23 (0.018) M
KmNCE
aCa Sodium-calcium exchanger calcium activation binding constant 1.66610
26 (0.238) M
b
mNCE
Ca Sodium-calcium exchanger calcium activation constant 67.6 (0.296) unitless
VmNHE
max Sodium-hydrogen exchanger max rate 9.45610
5 (0.061) nmol/min/mg
VHK
max Hexokinase max rate 1.20610
5 (5.14) nmol/min/mg
abbrev: LSC, local sensitivity coefficient (Note, the LSC is an average of the absolute value 1
st order sensitivity of a parameter with respect to all state variables, time
points and experimental conditions used in this study. It is explicitly defined in Equation 2. In brief, a d change in a given parameter translates to a dLSC change in the
model output defined in the Sensitivity Analysis section of the Methods.).
doi:10.1371/journal.pcbi.1000632.t002
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PLoS Computational Biology | www.ploscompbiol.org 6 January 2010 | Volume 6 | Issue 1 | e1000632Figure 2. Model simulations (lines) of the Pi control exerted over mitochondrial bioenergetics shown in comparison with isolated
mitochondria experimental data (symbols) for the conditions outlined in Bose et al. [8]. Mitochondria were incubated in the assay buffer
identified in the Methods sectionunder the Bose data set description.State2 simulation results andexperimental data areshown assolidlines andcircles,
respectively. State 3 simulations results and experimental data are shown as dotted lines and squares, respectively. The simulated Pi-titration response is
shown withthe experimentallymeasureddatafortheA)MVO2,B)redoxstate (percentNADH),C) Dy, D)reducedcytochromec (percentc
2+),E)matrixpH
and F) the simulated matrix volume.
doi:10.1371/journal.pcbi.1000632.g002
Figure 3. Model simulations (lines) of pyruvate/malate supported respiration on the levels of various TCA cycle intermediates
compared with isolated mitochondria experimental data (symbols) for the conditions outlined in LaNoue et al. [9]. Mitochondria were
incubated in the assay buffer identified in the Methods section under the LaNoue data set description. State 2 simulation results and experimental
data are shown as solid lines and circles, respectively. State 3 simulations results and experimental data are shown as dotted lines and squares,
respectively. The simulated TCA intermediate dynamics is shown with the experimentally measured data for A) the pyruvate utilization, B) the
accumulation of lumped citrate and isocitrate, C) the accumulation of extra-mitochondrial lumped citrate and isocitrate, D) the accumulation of
a-ketoglutarate, E) the accumulation of succinate and F) the residual malate content.
doi:10.1371/journal.pcbi.1000632.g003
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23 with a variance of 3.23610
24.
These low sensitivities for the model parameter values did not
reveal any inherent problems with the model structure.
The model was also able to reproduce the well known
mitochondrial shrinkage/swelling dynamics in the presence of Pi
and ADP. Figure 2F shows that as the extra-mitochondrial Pi-
titration was increased, mitochondrial matrix water volume
increased with the state 3 volume being lower than the state 2
volume. Unfortunately, no volume data for the Bose data set was
given; however, the model results do corroborate the qualitative
observations presented therein with volume increasing for higher
amounts of Pi in the medium.
The model was directly corroborated by predicting the steady
state accumulation of extra-mitochondrial a-ketoglutarate during
state 2 respiration at various extra-mitochondrial malate concen-
trations as shown in Figure 7. As the extra-mitochondrial malate
concentration was increased, the total amount of a-ketoglutarate
generated from the oxidation of pyruvate was also increased
and exchanged with the malate in the media via the oxoglutarate-
malate exchanger. This exchanger is a critical component of the
malate-aspartate shuttle and is particularly important in heart
tissue.
Figure 4. Model simulations (lines) of pyruvate supported
respiration on the levels of the amino acids aspartate and
glutamate in comparison with isolated mitochondria experi-
mental data (symbols) for the conditions outlined in LaNoue et
al. [9]. Mitochondria were incubated in the assay buffer identified in
the Methods section under the LaNoue data set description. The
simulated accumulation of aspartate (solid line) and glutamate (dotted
line) are shown with experimentally measured aspartate (circles) and
glutamate (squares). A) State 2, B) State 3.
doi:10.1371/journal.pcbi.1000632.g004
Figure 5. Model simulations (lines) of the steady state matrix
free calcium relationship with respect to varying extra-
mitochondrial calcium levels in comparison with isolated
mitochondria experimental data (symbols) for the conditions
outlined in Wan et al. [10]. Mitochondria were incubated in the assay
buffer identified in the Methods section under the Wan data set
description. The steady state matrix free calcium concentration is
shown versus varying extra-mitochondrial calcium in the presence of 2
(solid line, circles), 5 (dashed, squares) and 20 (dotted line, diamonds)
mM NaCl with 5 mM MgCl2.
doi:10.1371/journal.pcbi.1000632.g005
Figure 6. Model simulations (lines) of the matrix volume
dynamics under various altered states of the mitochondrial
bioenergetics shown in comparison with isolated mitochon-
dria experimental data (symbols) for the conditions outlined in
Kowaltowski et al. [11]. Mitochondria were incubated in the assay
buffer identified in the Methods section under the Kowaltowski data set
description. A small amount of ATP, 200 mM, was included in the assay
buffer with either 0.5 mg/mg oligomycin (solid line, circles), 1 mM ADP
(dashed line, squares) or 0.5 mg/mg oligomycin+1 mM ADP (dotted line,
diamonds). In a separate experiment, no ATP was included in the assay
buffer with 0.5 mg/ml oligomycin (dash-dot line, triangles).
doi:10.1371/journal.pcbi.1000632.g006
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experimentally observed mitochondrial volume dynamics after
various bioenergetic and/or mKATP interventions. Figure 8
shows that when the mKATP channel was manipulated via
normal or pharmacological pathways, the model was capable of
predicting the matrix volume changes observed. This highlights
the interactions between K
+-influx via mKATP and mKleak and
K
+-efflux via mKHE and identifies their role in mitochondrial
volume regulation. Upon energization, electrophoretic uptake of
K-salts increased matrix volume in an osmotic fashion. The first
principles representation of mitochondrial volume dynamics was
captured well by the model.
Finally, the model’s ability to reproduce the expected trends in
bioenergetic variables under varying KCl buffer osmolarity
conditions was explored. Devin et al. [12] monitored changes in
state 2 and state 3 Dy, matrix pH, proton motive force, MVO2,
NADH level and matrix volume as the buffer osmolarity was
changed from a hypoosmolar to a hyperosmolar KCl medium
using rat liver mitochondria. Although the model presented in this
manuscript was optimized to reproduce experimental data
primarily from heart tissue, the effect of varying medium
osmolarities on key bioenergetic variables was qualitatively
reproduced. Only a partial quantitative comparison to this data
was possible due to tissue source differences, experimental
limitations, and model structure (as further described in the
Discussion). Figure 9A shows that the simulated state 2 MVO2
matched the experimental trend; however, the model simulated
the incorrect trend for state 3 MVO2. This is attributed to the
tissue source and model structure detailed below in the Discussion.
The simulated Dy trends matched the reported experimental
trends (state 2: 2140 to 2160 mV and state 3: 2125 to
2135 mV) as shown in Figure 9B. Also, the simulated DpH
(pHmtx-pHims) trends matched the reported experimental trends
(state 2: 230 to 245 mV and state 3: 235 to 250 mV) as shown
in Figure 9C. Although the simulated Dys and the DpHs are over-
and underestimated, respectively, the proton motive force (Dy +
2.303RT/F DpH) matched the experimental data very well as
shown in Figure 9D. In other words, as the medium osmolarity
varied the total thermodynamic driving force established by the
ETS was very similar to that observed experimentally. Devin et al.
observed that from hypoosmotic conditions, the NADH levels
increased and leveled off as the buffer osmolarity was increased
towards hyperosmotic conditions. As shown in Figure 9E, the
model was able to reproduce this trend very well. They also
reported that in hyperosmotic KCl medium, mitochondrial matrix
volume is efficiently regulated, such that the steady state volume is
essentially retained, but in hyposomotic KCl medium, the matrix
volume dramatically increases relative to isoosomotic conditions
Figure 7. Model predictions (line) of the steady state extra-
mitochondrial a-ketoglutarate concentrations during state 2
respiration with various extra-mitochondrial malate concen-
trations (symbols) is compared to the experimentally reported
values outlined in LaNoue et al. [9]. Mitochondria were incubated
in the assay buffer identified in the Methods section under the LaNoue
data set description. Extra-mitochondrial malate was incrementally
increased from 0 to 5 mM in the presence of 2 mM pyruvate. The
model was simulated at sufficient times to achieve a-ketoglutarate
steady state concentrations.
doi:10.1371/journal.pcbi.1000632.g007
Figure 8. Model predictions (lines) of mitochondrial volume in
comparison with isolated mitochondria experimental data
(symbols) for the conditions outlined in Kowaltowski et al.
[11]. Mitochondria were incubated in the assay buffer identified in the
Methods section under the Kowaltowski data set description. A) In each
case, 200 mM ATP was included in the assay buffer. Volume dynamics
were then measured with either 1 mM ADP and 30 mM diazoxide (solid
line, circles) or 1 mM ADP, 30 mM diazoxide and 300 mM 5-hydro-
xydecanoate (dashed line, sqaures) added to the assay buffer. B) In each
case, 0.5 ug/ml oligomycin was included in the assay buffer. Volume
dynamics were then measured with either 200 mM ATP (dashed line,
circles); 200 mM ATP and 30 mM diazoxide (solid line, square) or 200 mM
ATP, 30 mM diazoxide and 300 mM 5-hydroxydecanoate (dash-dot line,
diamond) added to the assay buffer (note, the dash-dot line is hidden
by the solid line).
doi:10.1371/journal.pcbi.1000632.g008
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adequately reproduced this phenomenon. Overall, the model
corroborated the trends of the changes in bioenergetic variables as
buffer osmolarity varies.
Discussion
The model presented in this manuscript is based on previous
models [1–4] and includes integrated calcium dynamics and a
detailed description of the K
+-cycle and its effect on mitochondrial
bioenergetics and matrix volume regulation. Simulations were
used to fit 42 adjustable parameters to four independent
experimental data sets consisting of 32 data curves of both
transient and steady state data. A sensitivity analysis was
performed on the model to reveal the most sensitive components
of mitochondrial bioenergetics relative to the experimental
conditions modeled herein and revealed no inherent model
structural problems. Finally, several simulations were performed
to corroborate the model.
The mitochondrial volume dynamics and the associated K
+-
cycle appear to play an important role in cellular and
mitochondrial bioenergetics [15,38]. Energy transduction, namely
adenine nucleotide outer membrane permeability, is regulated
under both physiological and pathophysiological conditions [39].
The IMS volume is partly responsible for this regulation by having
a direct effect on the cellular bioenergetics in vivo [38]. For
example, the adenine nucleotide outer membrane permeability is
typically high in freshly isolated mitochondria due to matrix
contraction following potassium depletion. During mitochondrial
swelling, the increase in matrix volume causes a reciprocal
decrease in IMS volume that enables creatine kinase to bind to
the voltage-dependent anion channel thus reducing the adenine
nucleotide outer membrane permeability. Matrix contraction also
occurs in vivo during ischemia. This contraction interferes with the
regulation of the adenine nucleotide outer membrane permeabil-
ity, thereby enabling mitochondria to burn up all the cells
available ATP and primes the cell for apoptosis before reperfusion.
As a natural defense, potassium influx via mKATP increases
matrix volume and helps mitigate the detrimental effects of
increased adenine nucleotide outer membrane permeability [38].
As a first step to consider these important volume regulatory
events, the model incorporates simple volume dynamics based on
osmotic pressures generated by the K
+-cycle and other associated
processes. Future work studying this intricate energy transduction
mechanism is in the beginning stages of development.
The hypothesized volume-dependent mKHE by Garid [15] was
incorporated into the model. This volume dependence is necessary
to maintain sufficient potassium efflux at high Dy during mKATP
opening. Without this dependence, the mKHE would be an
ineffective volume regulatory mechanism, and the outer mem-
brane would rupture. Specifically, potassium influx induced upon
mKATP opening is maintained and essentially constant at a given
Dy because the current cannot sufficiently depolarize the Dy and
because of thermodynamic considerations [33]. Also, model
simulations revealed that matrix free Mg
2+ only decreased from
0.4 mM to approximately 0.15 mM (depending on total amount
of Mg-ligands, such as ATP and Pi, present in the matrix and the
matrix volume) under the experimental conditions. This decrease
is insufficient to serve as the primary volume controller required by
the carrier-brake hypothesis. These observations require that
mKHE posses some sort of volume dependence enabling an
effective volume controlling mechanism. This hypothesis was
supported by simulation results presented in Figures 6, 8 and 9F
whereby the exquisite control of matrix volume exhibited by
mKHE was revealed.
Figure 9. Model predictions (lines) of mitochondrial bioenergetic parameters under differing osmotic KCl medium with isolated
mitochondria experimental data (symbols) for the conditions outlined in Devin et al. [12]. Mitochondria were incubated in the assay
buffer identified in the Methods section under the Devin data set description. As the osmotic pressure of the KCl medium was adjusted from
hypoosmotic to hyperosmotic conditions, A) MVO2,B )Dy,C )DpH (defined as pHmtx-pHcyt), D) proton motive force (Dy+2.303RT/FDpH), E) %NADH
level and F) matrix volume predicted by the model is presented.
doi:10.1371/journal.pcbi.1000632.g009
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topology had to be in place and some assumptions about uncertain
or unobserved experimental factors and conditions were explicitly
constrained. It was found that these network features and
experimental assumptions described below were necessary to
successfully recreate all the experimentally observed data and
trends. The necessity of these realizations contributes to our
collective understanding of the mitochondrial bioenergetics.
The intrinsic thermodynamic dissipation of a system can
override or mitigate enzymatic regulation [40]. For example, in
glutamate/malate energized mitochondria, aKGDH serves as a
key regulatory enzyme responsible for maintaining sufficient
NADH levels sustaining MVO2 rates in state 2 and state 3. This
reaction is far from equilibrium making it sensitive to its regulatory
mechanisms. In contrast, malate dehydrogenase (MDH) is much
closer to equilibrium so its regulatory mechanism less effectively
controls the dehydrogenase rate. In state 2, aKGDH is a major
enzyme in the pathway responsible for regenerating the matrix
ATP that is consumed by the F1FO ATP synthase to help the ETS
establish a high Dy. In state 3, this enzyme’s activity helps dictate
which path the carbon substrates flow through the TCA cycle.
The regulation for this enzyme helps enable mitochondria to
achieve the steady state NADH levels observed with the Bose Pi-
titration data seen in Figure 2B. The relative rates identified from
the model simulations (not shown) predicted that the regulation of
MDH played less of a role in the steady state NADH Pi-dependent
levels than the regulation of aKGDH.
Animal model species specific parameterization may be
required for detailed mathematical models of the mitochondrial
bioenergetics; however, at this time there is not sufficient data
from a single species to fully characterize the dynamics. For
example, all the kinetic parameters for the aKGDH expression
were found using independent data sets obtained from porcine
heart mitochondria as described in Part S3 of the Supplemental
Material (Text S1) [18–21]. Only VaKGDH
max , the maximum rate
constant, was refit with the fully integrated model simulations that
used data from both porcine and rat heart mitochondria. Future
compensation for the species specific enzyme kinetic differences
between these two isozymes may further improve the fit of the
simulated a-ketoglutarate dynamics to the experimental data in
Figure 3D.
The tissue type used for the supporting experiments is also
important for parameterization of a semi-mechanistic mathemat-
ical model. For example, in the model, several exchangers and
cotransporters are reported to possess low activity in heart tissue
compared with other tissues [41]. Although the definition for low
activity was ambiguous; herein to reproduce the experimental
data, it was necessary that some of these processes possess
unexpectedly elevated activities. For example without sufficiently
active glutamate-H cotransport, the model was unable to
reproduce the observed aspartate/glutamate dynamics reported
by LaNoue et al. [9] in Figure 4. The glutamate-H cotransporter is
responsible for the electroneutral transport of the amino acid
glutamate and a proton through the inner-mitochondrial mem-
brane down a concentration gradient. This provides a glutamate
leak pathway that reduces the matrix aspartate/glutamate pool.
Reducing aspartate availability in the matrix prevents the
thermodynamically favorable reaction catalyzed by GOT from
consuming all of the endogenous aspartate. Alternatively to the
proposed elevation in the activity of the cotransporter, it has been
argued that there may be two separate aspartate pools [42] in
mitochondria. Compartmentalizing the total aspartate pool with
slow or volume-dependent transport rates would also enable the
model to reproduce the aspartate/glutamate dynamics in the
LaNoue data set. As further indirect support for the proposed
elevated glutamate-H cotransporter activity, increased glutamate
influx helps enable state 2 and state 3 respiration on glutamate and
malate for the Bose data set simulations as shown in Figure 2. At
this point, neither mechanism has been proven experimentally.
Another exchanger reported to possess low activity in heart
tissue is the dicarboxylate carrier [43]. This carrier is responsible
for the exchange of primarily Pi, malate and succinate. However,
without sufficiently high activity, the succinate-energized mito-
chondrial matrix volume data reported by Kowaltowski et al. [11]
could not be reproduced by the model. Elevated DCC rates were
necessary to provide sufficient succinate influx allowing electro-
phoretic potassium uptake. If the DCC activity was limited to the
reported maximum rate [44], the mitochondrial Dy would not
polarize substantially and mitigate the reported potassium-
dependent volume increase.
The chosen substrates for the DCC also affected the model
simulation capabilities. In the model formulation, only Pi, malate
and succinate were assigned as the DCC substrates. Fumarate is
also reported to be a substrate for the DCC [45] but was not
included in the model due to insufficient data to characterize the
kinetics. Including fumarate in the list of the DCC substrates
would enable to the model to reproduce the accumulated fumarate
data from LaNoue data set (not shown). Also, the omission of
fumarate as a substrate for the DCC in addition to the DCC
elevated activity contributed to the simulated state 3 malate net
oxidation present in Figure 3F.
An additional tissue source related phenomena uncovered
during model development was the choice of the calcium
dissociation constant for the CaUNI. During model development,
a single calcium dissociation constant was chosen to model the
CaUNI kinetics from rat heart and liver tissue. This was achieved
by considering the competitive nature of magnesium inhibition
with respect to calcium binding. It is plausible that the major
difference between liver and heart CaUNI kinetics is due to
different expression levels versus different calcium binding
affinities (as may be plausible between different species); however,
more research concerning this matter needs to be done.
Mitochondria from specific tissue types are phenotypically
different and contain various amounts of electron transport
proteins, matrix proteins and lipid types optimized to support
their designated function. Specifically, heart mitochondria possess
much higher electron transport activity relative to liver mitochon-
dria [46]. Therefore, we partially attribute the discrepancies
between the simulated and reported values for the MVO2, Dy and
DpH, and under varying KCl buffer osmolarity conditions to
differences in the tissue source. The experiments outlined in Devin
et al. [12] were done using mitochondria isolated from rat liver
while the model was primarily developed to fit data obtained
from heart tissue. This is exemplified in Figure 9A–C. The model
simulated much higher state 3 MVO2 rates (200 versus
100 nmolO/min/mg); however, the state 2 MVO2 trends
(quantitative data not given) matched those reported. The
measured liver mitochondria Dys were several 10 s of mVs lower
relative to simulated Dys and is also partially attributed to the
model’s overestimation of state 3 Dy seen in Figure 2C. Although
the Dy and DpH energetic variables were quantitatively different,
it is interesting to note that the thermodynamic variable (proton
motive force) was consistent across the tissue types as would be
expected. Moreover, the authors suggested that the measured
hypoosmolar Dy may have been in error due to volume
dependent rhodamine 123 accumulation. This accumulation
may partially account for the discrepancy between the measured
hypoosmotic state 2 proton motive and that simulated. Thus the
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response to varying buffer osmolarity under the conditions
presented in Devin et al. would produce Dys in the range of
2200 to 2140 mV, DpH in the range of 7 to 30 mV (0.2 to
0.5 pH units) and MVO2 rates in the range of 200 to 15 nmolO/
mg/min.
The translation of the biochemical processes to appropriate
mathematically descriptive expressions plays a large role in the
simulated dynamics. For example, the citrate and isocitrate
overestimation by the model as shown in Figure 3C is attributed
to the simple passive exchange process used to model the
tricarboxylate carrier (TCC). Replacing this exchange process
with a more kinetically descriptive mechanism [47] would help
prevent the simulated early accumulation of citrate and isocitrate;
however, there is insufficient data to parameterize such a
descriptive mechanism. Partially as a function of the simplified
description, the activity of the TCC is elevated even though it is
reported to possess low activity in heart tissue compared to that in
liver tissue [41]. Additionally, the passive TCC exchange process
required higher PDH rates in order to sustain sufficient citrate,
isocitrate, a-ketoglutarate and succinate levels during both state 2
and especially state 3 respiration seen in Figure 3. Together, the
TCC and DCC modeling approximations contribute to the
simulated higher malate net oxidation rates than those observed in
the LaNoue data set (Figure 3F) since the TCC also exchanges
malate across the inner-mitochondrial membrane [47].
During the model development, it is important to consider any
artifacts in the experimental data that may have been inadver-
tently generated during the mitochondrial isolation. For example,
the extraction medium must contain Pi to achieve stable, well-
coupled mitochondria [41]. To enable the Bose study with Pi-
depleted mitochondria, a special isolation procedure was neces-
sary. This Pi-depletion method may have dramatically changed
some of the mitochondrial protein phosphorylation states thus
having an unknown regulatory effect [48]. Within the short time
scales of the Bose experiments, the slower phosphorylation and
dephosphorylation events may not have sufficiently occurred upon
the Pi-titration. Specifically, the Pi-depletion method may have
altered the proton permeability via cation/proton exchange and/
or anion/proton cotransport activity. In these experiments, the
buffer pH was fixed at 7.1. With the mKHE rate expression
identical to that used with the other data sets, the simulated Dy is
underestimated while the DpH is overestimated, but the total
energetic contribution from both Dy and DpH was nearly
identical to that reported. This compensation results from their
thermodynamic equivalence with some important kinetic differ-
ences. To achieve the low DpH values reported experimentally,
the volume-dependent mKHE expression had to be replaced with
a high activity K
+/H
+ exchanger. It is postulated that the Pi-
depletion dramatically altered the proton permeability. This is
manifested in the model by essentially creating a high activity
rapid equilibrium exchanger mechanism that is not supported by
the volume-dependent mKHE expression. However, this high
activity K
+/H
+ exchanger is not compatible with the volume
dynamics presented in the Kowaltowski data set, so it is only used
for the Bose data set simulations since their isolation procedure
was done without Pi. Although we chose to address this
discrepancy using a high K
+/H
+ exchanger, there are several
alternative mechanisms that could also potentially describe or
contribute to the DpH discrepancy. For example, the mNHE
could be responsible for converting more of the DpH into the Dy
than the model predicted. It is possible the mNHE activity is
underestimated; however, the models ability to match the reported
steady state matrix free calcium concentration at varied buffer
sodium concentrations shown in Figure 5 indicate this is not the
case. Alternatively, the differences between porcine and rat heart
mitochondria may be responsible for the dramatic change in
proton permeability. The Bose data set was obtained using porcine
heart mitochondria, while rat heart mitochondria were used for all
the other datasets. It is not likely that the proton permeability
associated with these two species is significantly different.
Conversely, the volume-dependent mKHE expression may not
sufficiently capture the phenomena. The model fits and corrob-
oration simulations presented in Figure 6 and Figure 8, respec-
tively, refute this conclusion. From this discussion, it is evident that
more experimental data measuring DpH and Dy under various
conditions is needed to reduce this uncertainty.
To simulate the precise experimental conditions during model
development, a few explicit assumptions were necessary. For
example, the LaNoue data set reported using 3–4 mg of
mitochondrial protein; however, as little as a 25% change in
mitochondrial load can dramatically alter the total substrate
consumption and product accumulation during high MVO2 rates.
Hence for these simulations, the conditions needed to be known
with more certainty. The reported malate concentration was used
to estimate the mitochondrial load. The initial malate content in
state 2 and state 3 experiments with pyruvate was reported to be
1430 nmol/mg. This required that the mitochondrial load be
3.5 mg/mL using the stated 5 mM malate concentration. To
compute this estimate, it was necessary to also consider the
pyruvate concentration. The pyruvate concentration was 2 mM;
however after 8 minutes of state 3 respiration, the pyruvate
utilization was 848 nmol/mg. Considering the 1 mL chamber
volume, this implied that the total initial pyruvate concentration
was 2.5–3.4 mM and not 2 mM. In an attempt to address these
potential data inconsistencies, the model simulations were fit to the
data using a mitochondrial load of 3.5 mg/mL and the reported
state 3 pyruvate utilizations were subsequently adjusted to be
consistent with an initial pyruvate concentration of 2 mM.
All mathematical models are abstractions of the underlying
process; the level of detail included in the model is dependent upon
the application. This is particularly true for the calcium dynamics
associated with mitochondrial bioenergetics. There are known
omissions in this and previous models of these calcium dynamics.
The mitochondrial Na
+/Ca
2+ dynamics were simulated using a
simplified Na
+/Ca
2+ cycling mechanisms with only the CaUNI,
mNCE and mNHE processes represented. This simplification
prohibited a mechanistic representation of the actual physiological
event. For example, the omission of the rapid mode of calcium
uptake (RAM) [49] process necessitated a high CaUNI influx to
reach the steady state calcium measurements (from the Wan data
set) within a few minutes of extra-mitochondrial calcium addition.
(Note, with this higher calcium influx rates, the model still predicts
the Na
+/Ca
2+ cycle consumes less than 1% of the proton
electrochemical gradient established by the ETS.) Also, the Na
+-
independent calcium efflux mechanism is not included in the
model formulation since the underlying process is uncertain
(electroneutral or electrogenic [50–52]) even though it is estimated
to contribute up to 33% of total calcium efflux in heart tissue [53].
This omitted calcium efflux mechanism is insensitive to magne-
sium and prevented adequate fits to the Mg
2+-titration data
presented in Wan et al.; however, Mg
2+-dependence of the
CaUNI and mNCE did enable the simulations to reproduce the
reported steady state matrix calcium levels within a few 100 nM
(not shown). An explicit, detailed study of the Na
+/Ca
2+ dynamics
should be modeled under various experimental conditions to fully
characterize and understand this process at a more mechanistic
level.
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an extended mitochondrial bioenergetics model targeted at the
cardiac myocyte with the parameters estimated using four
independent data sets consisting of 32 data curves. It was capable
of fitting the data with good fidelity, had relatively little parameter
sensitivity relative to the experimental conditions modeled herein
and was capable of adequately modeling metabolic trends during
the various conditions simulated. The resulting model simulations
reproduce observed mitochondrial volume dynamics lending
additional support to the current prevailing theory of mitochon-
drial volume regulation through the mKHE volume-sensitive
exchange rate. The model builds upon previous successes and
helps refine and establish a global model framework relating to
mitochondrial bioenergetics. During the model development, a
certain network topology had to be in place and some assumptions
about uncertain or unobserved experimental factors and condi-
tions were explicitly constrained to reproduce all the data sets.
Specifically, the effect of intrinsic thermodynamic dissipation of
the system on enzymatic regulation, importance of animal species
and tissue sources differences, mechanistic detail of the model and
potential impact of the experimental environment all help
constrain the model formulation contributing to the construction
of a successful and physiologically faithful model.
The model can serve as a foundation for further extension and
refinement efforts. Future work may consider more detailed and
mechanistic mathematical abstractions for the ETS and TCC,
Ca
2+ dynamics including the RAM and Na
+-independent Ca
2+
efflux pathways, catabolic (i.e., glutamate dehydrogenase) and
anabolic (i.e., pyruvate carboxyalse) reactions and b-oxidation
pathways enabling integration into whole cell models of cardiac
myocytes. Each of these additions will require additional
experimental data taken under well controlled and documented
conditions in order to be properly reproduced by the model
proposed in this manuscript. For example, changing the passive
exchange mechanism of the TCC to a more mechanistic, saturable
exchange process should enable better fits to the LaNoue data set.
This change would keep matrix citrate and isocitrate at sufficient
levels to maintain a-ketoglutarate and succinate concentrations
experimentally observed allowing fumarate to be included in the
list of DCC substrates. With fumarate being removed from the
matrix by the DCC, SDH inhibition would be mitigated and the
lower branch of the TCA cycle would accelerate and prevent net
oxidation of malate observed in the LaNoue experimental data set.
Additionally, reproducing the respiratory control ratios as done in
silico by Korzeneiwski and Mazat [54] using the experimentally
measured respiratory control ratios measure by Rossignol et al.
[55] would help constrain, define and corroborate the mathemat-
ical abstractions for the ETS, F1FO, ANT and PYRH mecha-
nisms. Experiment design with this model could further reduce
parameter uncertainties and help test alternative hypotheses
including some postulates made in the Discussion. Although much
work is ahead, we feel that this model takes a step towards a more
complete physiologically faithful mitochondrial bioenergetics
model.
Methods
Numerical Solutions
The DAEs describing the model were numerically integrated
using MATLABH (2008b) and the stiff ode solver ode15s (10
23
relative tolerance and 10
29 absolute tolerance for matrix and IMS
state variables and 10
26 for all others). To increase computational
efficiency, vectorized functions were used during model develop-
ment in the MATLABH environment. Parameter optimizations
and sensitivity analyses were done on a cluster of four 8-core Intel
Xeon 3.4 GHz CPUs each with 16 GB of memory and running
the Windows 2003 server platform using the Parallel Computing
Toolbox. The results obtained were displayed using MATLABH.
Objective Function
The objective function used for parameterization of the model
is defined as
fp ðÞ ~
X
k
1
Mk
X Mk
j~1
1
Nj,k
X Nj,k
i~1
yi,j,k p ðÞ {Yi,j,k
si,j,k
   2
ð1Þ
where f is the objective function evaluated at a given parameter
point p, yi,j,k is the model output, either a state variable or
computed rate, corresponding to the ith experimental data point
in the jth experimental data curve for the kth data set evaluated at
the parameter point p, Yi,j,k is the ith experimental data point in
the jth experimental data curve for the kth data set, si,j,k is the
standard deviation for the ith experimental data point in the jth
experimental data curve for the kth data set, Nj,k is the number of
data points in the jth experimental data curve for the kth data set
and Mk is the number of data curves for the kth data set. When no
statistical data were given with the experimental data, a 5–10%
relative error was assumed.
Parameter Identification
Fitting such large, non-linear models to data with many
unknown parameters and initial conditions requires a robust
model structure and many independent data sets to appropriately
constrain the parameters. The model presented in this manuscript
consists of a total of 359 parameters. These parameters were
identified using three methods: i) 262 parameters were fixed
according to previously published values in the literature (see Part
S3 of the Supplemental Material (Text S1)), ii) 55 parameters were
found by minimizing the sum of the squares of the difference
between simulated rate expressions and the published data using
Equation 1 (see Part S3 of the Supplemental Material (Text S1)),
and iii) a custom parallelizable Monte Carlo optimization
algorithm based on simulated annealing was used to fit the
remaining 42 parameters by minimizing Equation 1 with
replicated experiments [8–11]. Global candidate points were first
identified using the simulated annealing approach and refined with
a local search using a gradient-based algorithm (MATLABH’s
fmincon function).
Sensitivity Analysis
The local sensitivity analysis was done using the absolute
normalized local sensitivity coefficient (LSC) for quantifying how
much the model output trajectories for the simulated experimental
conditions changed in response to small perturbations about the
identified parameter set. This LSC is defined as
LSC ‘ ðÞ ~
1
H
X
k
1
Mk
X Mk
j~1
1
Nj,k
X Nj,k
i~1
Lyi,j,k
Lp‘
p ðÞ
p‘
yi,j,k p ðÞ
       
        ð2Þ
where LSC is the normalized local sensitivity coefficient for the ,th
parameter, yi,j,k is the model output of the ith state at the jth time
point for the kth experimental condition evaluated at the
parameter point p, p, is the parameter whose sensitivity is being
approximated, Nj,k is the number of states considered for the
analysis (note, all 73 states were included in the sensitivity analysis)
at the jth time point for the kth experimental condition, Mk is the
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5 equally spaced time points) for the kth experimental condition
and H is the total number of experimental conditions replicated
from [8–11]. (Note that although the indices used for the LSC
computation are similarly defined, they have different meaning.)
Equation 2 was approximated using a centered finite difference
using the numerical methods outlined in Conn et al. [56]. To
minimize numerical artifacts when computing the LSCs, the
model was integrated with stricter tolerances (10
29 relative
tolerance and 10
212 absolute tolerance tolerance for matrix and
IMS state variables and 10
29 for all others). This unit of measure is
used in Table 2 to discern the 1
st order, one-at-a-time, effects of
small parameter perturbations. A parameter that possesses a large
LSC is interpreted as having a substantial influence on the model
state trajectories and steady state values.
Simulating the Experimental Conditions
To simulate the various data sets used to parameterize and
corroborate the model, the appropriate experimental conditions
were taken into consideration. The temperature at which the
experimental data were obtained, the mitochondrial loads applied
in each experiment, the initial state of the mitochondria in the
experimental system and the precise nature of the experimental
environment, specifically the buffer composition and osmolarity
were considered. These points are discussed below.
Temperature dependence. The rates of biochemical
reactions can be extremely sensitive to temperature. A
temperature induced change in activity can easily result in
doubling or even tripling of some enzymatic reactions for a
temperature difference of only 10uC. Since the experiments used
to parameterize the model were done at different temperatures,
the rates were adjusted according to a standard Q10 value of 2.25
or based specifically on the enzyme’s activation energy and the
Arrhenius rate law. The Arrhenius rate law temperature
correction is only truly valid for reactions whose substrates are
in rapid equilibrium with their respective substrate-enzyme
complexes, and the catalysis step is rate limiting [57]. This
becomes significant when dealing with convex Arrhenius plots.
The source of convexity is controversial and usually involves
different active substrate-enzyme isoforms at different
temperatures. We assumed that even though some of the
biochemical reactions in the model were not reactions whose
substrate-enzyme species were in rapid equilibrium, we could still
obtain a reasonable approximation of the temperature correction.
In the case of an enzymatic reaction displaying a convex Arrhenius
plot, only the linear region in the temperature range of 4–37uC
was used to adjust the rates. Table S1.3 in the Supplemental
Material (Text S1) shows the compiled list of activation energies
used in this model study.
Model initialization. It is especially important to use the
appropriate initial conditions by either including them in the
fitting procedure as variables or conditioning the model by
simulation to set common initial operating conditions. We chose
the latter and standardized the initial conditions by simulating the
model for sufficiently long times with the experimental conditions
outlined in each paper. For example, the Bose data set was derived
from de-energized, equilibrated mitochondria, the LaNoue data
set was derived from de-energized, non-equilibrated mitochondria,
the Wan data set was derived from energized, equilibrated
mitochondria, the Kowaltowski data set was derived from de-
energized, non-equilibrated mitochondria and the Devin data set
was derived from energized, equilibrated mitochondria. Once the
model was simulated to its fully oxidized state, appropriate
modifications to state variables were performed to mimic the
experimental conditions as described in each paper used for
parameter estimation.
Mitochondrial loads. Each experiment used different
mitochondrial loads; therefore, for each data set, the buffer
water volume relative to the mitochondrial protein content was
varied. This is important because the higher the mitochondrial
load, the higher the absolute rate of consumption for carbon
substrates and oxygen making time series data essential for
parameterization purposes. The Bose data set experiments were
performed at a mitochondrial load of 1 nmolCyta/mL, or
approximately 1 mg mitochondria/mL [58–59]. The LaNoue
data set experiments used a much larger mitochondrial load of
3–4 mg mitochondria/mL. The reported 3–4 mg mitochondria/
mL for the simulations was averaged (as mentioned in the
Discussion). The Wan data set experiments were performed at
2 mg mitochondria/mL. The Kowaltowski data set experiments
used a mitochondrial load of 0.1 mg mitochondria/mL. The
Devin data set experiments reported using 1 mg/mL; however, for
the experimental conditions imposed, the liver mitochondria
maintained relatively low MVO2 rates (approximately 100 nmol
O/min/mg) for the duration of the 10 minute experiment. For
identical conditions, the model simulates MVO2 rates greater than
three times this value; therefore, in order to maintain pseudo-
steady state conditions for 10 minutes, the mitochondrial load had
to be adjusted to 0.1 mg/mL. This prevented the model from
simulating considerable ADP consumption rates in order to
maintain steady MVO2 rates for 10 minutes.
Bose experimental conditions. Before simulating the
experimental conditions (T=37uC) in the Bose data set, the
model had to be initialized to recreate the Pi-depleted state of the
mitochondria. This was done by simulating the model to its fully
oxidative state in the presence of ATP followed by a quick Pi-
depletion step. Unfortunately, the exact details concerning the Pi-
depletion protocol could not be found. For parameter estimation,
the basic buffer composition consisted of 125 mM KCl, 15 mM
NaCl, 20 mM K-Hepes, 1 mM KEGTA, 1 mM K2EDTA, 5 mM
MgCl, 4 mM TPP
+ at pH 7.1. The authors stated that the free
[Ca
2+] was generally held between 500 and 600 nM using CaCl2.
For simulation purposes, the free [Ca
2+] was fixed at 550 nM. To
initiate respiration, 5 mM glutamate/malate was added to the
buffer preceding the Pi-titrations for the simulations. For state 3
respiration, 1.3 mM ADP was added to the medium after the
glutamate/malate and Pi additions. For each Pi-titration, the free
[K
+], [Na
+] and [Mg
2+] were calculated based on the dissociation
constants defined in the Supplemental Material (Text S1). After
glutamate/malate was added to the buffer, the model simulated
the 60 second experiment reaching pseudo-steady state. Next, Pi
was added to the buffer and the model was simulated for the next
60 second experiment reaching another pseudo-steady state. To
conclude the experiment, ADP was added to the buffer and the
model was simulated for the 30 second experiment reaching its
final pseudo-steady state.
LaNoue experimental conditions. For the LaNoue data set
simulations (T=28uC), the model was first initialized to achieve
the fully oxidized state. The basic buffer composition used for
respiratory state initiation consisted of 150 mM KCl, 20 mM Tris-
Cl, 20 mM KPi, 5 mM MgCl2 and 30 mM glucose at pH 7.2.
The mitochondria were preincubated in the basic buffer
composition for 30 seconds before addition of substrates. For
state 2, either 2 mM pyruvate and 5 mM malate or 1 mM
pyruvate was added to the basic buffer composition, and the
model was simulated for the specified experimental time. (Note
that in the original reference, LaNoue et al. define state 4 as state 2
is defined in this manuscript. They used the previous state
Modeling Mito. Bioenergetics with Volume Dynamics
PLoS Computational Biology | www.ploscompbiol.org 14 January 2010 | Volume 6 | Issue 1 | e1000632nomenclature defined by Chance and Williams [60]. The
definitions used here are consistent with those defined by
Nicholls and Ferguson [61]). State 3 was simulated similarly,
except for the addition of 0.5 mM ADP. With the addition of
ADP, the free [K
+], [Na
+] and [Mg
2+] were recalculated based on
the dissociation constants defined in the Supplemental Material
(Text S1). A hexokinase trap was used to regenerate ADP in the
buffer. The simulated time was identical to that reported in the
experimental procedure.
Wan experimental conditions. The Wan Data set
simulations (T=28uC) also required model initializations from a
fully oxidized state. The buffer composition consisted of 130 mM
KCl, 20 mM HEPES, 5 mM MgCl2, 5 mM ATP, 5 mM
KH2PO4, 5 mM NaCl and 1 mM EGTA at pH 7.0. For the
Na
+- and Mg
2+-titrations, the free [K
+], [Na
+] and [Mg
2+] were
recalculated at each data point based on the dissociation constants
defined in the Supplemental Material (Text S1). ATP was included
to energize the mitochondria providing an electrophoretic driving
force for calcium uptake. The model simulated a 2 minute
experiment to ensure steady state and closely matches the time
observed in the original experimental procedure.
Kowaltowski experimental conditions. The Kowaltowski
data set simulations (T=28uC) were simulated from a fully
oxidative and pre-osmotic equilibration state. The basic buffer
composition used for respiratory state initiation consisted of
135 mM KCl, 5 mM succinate, 2.5 mM Pi, 100 mM EGTA,
0.5 mM MgCl2 at pH 7.2. They applied various bioenergetic
pharmaceutical interventions and measured the matrix swelling
dynamics. To block the F1FO ATP synthase, 0.5 mg/ml
oligomycin was used. To simulate this condition, the parameter
defining the enzyme activity, V
F1F0
maxf, was set to zero. When 30 mM
diazoxide, a mKATP channel opener, was used, the endogenous
inhibition of the mKATP channel was set to zero. When 300 mM
5-hydroxydecanoate, a mKATP channel closer, was used, the
parameter defining the channel conductance, GmKATP, was set to
zero. The simulated times are identical to the times reported in the
original experimental procedure.
Devin experimental conditions. For the Devin data set
simulations (T=26uC), the model was first initialized to achieve
the fully oxidized state. The basic buffer composition used for
respiratory state initiation consisted of 5 mM TPMP
+,5 mM
DMO, 5 mM manitol, 20 mM Tris-HCl, 1 mM EGTA, 6 mM
Tris-glutamate, 6 mM Tris-malate, 5 mM Tris-Pi at pH 7.2 with
varying amounts of KCl used to adjust the osmolarity. The buffer
[K
+] was approximated by setting it equal to half the reported
osmolarity. Since no divalent cation was present in the medium,
the adenylate kinase reaction was turned off. The model was
simulated under state 2 conditions until steady state was reached (a
simulated time of 5 minutes) under the varying osmotic conditions.
Then, at each osmotic condition, 1 mM of ADP was added to the
buffer and the model was simulated to a pseudo-steady state
reproducing the reported 10 minute experiments.
Supporting Information
Text S1 The supplemental material consists of three parts. Part
S1 lists the state variables comprising the model, updated Gibbs
free energy of formation values, additional and revised dissociation
constants, temperature correction method, and general model
parameters. Part S2 introduces of the set of 60 non-linear ODEs,
five algebraic conservation expressions (for ATP, GTP, NADH,
UQH2 and c
2+), five matrix cation ODEs (for H
+,K
+,N a
+,M g
2+
and Ca
2+) and the algebraic expressions for computing matrix and
intermembrane space (IMS) water volumes and matrix Cl
2 is
presented. Part S3 discusses the model rate equation derivations
and provides all the associated parameter definitions and values.
Found at: doi:10.1371/journal.pcbi.1000632.s001 (2.73 MB
DOC)
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